MehmetDemirhanMD

PubMed

• 1 citations
  Defining Key Features of Complex Coronary Lesions: An Evidence Based Review of Clinical Practice. Part II: Chronic Total Occlusions, Graft Interventions, In-Stent Rest...
  Daniel Feldman, Frans Beerkens, Johny Nicolas, Mohan Satish, Davis Jones
  Reviews in Cardiovascular Medicine. 2022-06-01
• Corticosteroid-Refractory Myositis After Dual BRAF and MEK Inhibition in a Patient with BRAF V600E-Mutant Metastatic Intrahepatic Cholangiocarcinoma.
  Timothy P DiPeri, Mehmet Demirhan, Daniel D Karp, Siqing Fu, David S Hong
  Journal of Immunotherapy and Precision Oncology. 2022-02-01
• 36 citations
  Combining Neratinib with CDK4/6, mTOR, and MEK Inhibitors in Models of HER2-positive Cancer.
  Ming Zhao, Stephen Scott, Kurt W. Evans, Erkan Yuca, Turcin Saridogan
  Clinical Cancer Research. 2021-01-07

Journal Articles

• Long-Term Use of Everolimus plus Octreotide for Recurrent Intracranial or Spinal Meningioma: A Single Institution Experience  
  Michael Youssef, Lily Pham, Mehmet Demirhan, Rebecca Harrison, Monica Loghin, Jennifer Johnson, Kristin Alfaro-Munoz, Krishna Bhat, Debra Yeboa, Sujit Prabhu, Shaan Ra..., Neuro-Oncology, 11/9/2020

Books/Book Chapters

• Phase I Oncology Drug Development 
  Chapter: Pharmacokinetic considerations for organ dysfunction clinical trials in early drug development 
  Azaro, A, Demirhan ME, Lim J, Rodon Ahnert J.Editors: Timothy A. Yap, Jordi Rodon, David S Hong.Springer2020

Abstracts/Posters

• Clinical Outcomes of Hyponatremia in Patients Undergoing TAVR - A National Inpatient Sample Database
  Yasar Sattar, Waqas Ullah, Salman Zahid, Houman Moussa Pacha, Uneza Rauf Khawaja, Fahed Darmoch, Mohamad Soud, Yasser Alkhadra, Mehmet E Demirhan, Urja Patel, David L ..., Circulation, 11/12/2020
• Combinatorial therapies of neratinib for HER2-amplified cancer
  Ming Zhao, Stephen Scott, Kurt Evans, Erkan Yuca, Turcin Saridogan, Mehmet E Demirhan, Bryce P Kirby, Scott Kopetz, Irmina Diala, Alshad S Lalani, Sarina A Piha-Paul a..., AACR-NCI-EORTC International Conference, Boston, 10/30/2019
• Identification of Actionable Genomic Alterations Using Circulating Cell-Free DNA
  Sánchez NS, Bailey AM, Wathoo C, Balaji K, Demirhan ME, Yang D, Kahle MP, Javle M, Kaseb A, Eng C, Subbiah V, Janku F, Raymond V, Lanman RB, Mills- Shaw KR, Meric-Bern..., ASCO, Chicago, 6/5/2018